Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 12/20 | 0.61 |
| ▸ | PGR | P06401 | 2/20 | 0.61 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.39 |
| ▸ | UBE2M | P61081 | 1/20 | 0.36 |
| ▸ | DCUN1D1 | Q96GG9 | 1/20 | 0.36 |
| ▸ | RXRA | P19793 | 1/20 | 0.36 |
| ▸ | RXRB | P28702 | 1/20 | 0.36 |
| ▸ | RXRG | P48443 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4895835 | 1.00 | AR (0.61) | ARPGRS1PR1UBE2MDCUN1D1 | |
| SCHEMBL4907347 | 0.93 | AR (0.71) | ARPGRS1PR1UBE2MDCUN1D1 | |
| SCHEMBL4901392 | 0.93 | AR (0.71) | ARPGRS1PR1UBE2MDCUN1D1 | |
| SCHEMBL4595465 | 0.90 | AR (0.66) | ARPGRS1PR1RXRARXRB | |
| SCHEMBL4906362 | 0.87 | AR (0.74) | ARPGRS1PR1UBE2MDCUN1D1 | |
| SCHEMBL4906358 | 0.87 | AR (0.74) | ARPGRS1PR1UBE2MDCUN1D1 | |
| SCHEMBL4595653 | 0.83 | AR (0.85) | ARPGRS1PR1RXRARXRB | |
| SCHEMBL4595656 | 0.83 | AR (0.85) | ARPGRS1PR1RXRARXRB | |
| SCHEMBL4594538 | 0.83 | AR (0.52) | ARPGRS1PR1UBE2MDCUN1D1 | |
| SCHEMBL4594539 | 0.83 | AR (0.52) | ARPGRS1PR1UBE2MDCUN1D1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080194536-A1 | Cyanoarylamines | SMITHKLINE BEECHAM CORPORATION | 2008-08-14 | — | — | US | claimed |
| US-20080194536-A1 | Cyanoarylamines | SMITHKLINE BEECHAM CORPORATION | 2008-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080194536-A1 | Cyanoarylamines | EDNRA, CYP19A1, HSD17B11 | AR 84/4885PGR 64/4885S1PR1 1327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.